116096001: Rosiglitazone maleate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\...

\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Rosiglitazone maleate

\Peroxisome proliferator-activated gamma receptor agonist\Thiazolidinedione (substance)\Rosiglitazone maleate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Rosiglitazone maleate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Rosiglitazone maleate

\Organic compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Rosiglitazone maleate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

177440011 Rosiglitazone maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

674905017 Rosiglitazone maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

36131000188112 rosiglitazone maléate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

838871000172115 maléate de rosiglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rosiglitazone maleate	Is a	Product containing thiazolidinedione (product)	false	Inferred relationship	Some
Rosiglitazone maleate	Is a	Thiazolidinedione (substance)	true	Inferred relationship	Some
Rosiglitazone maleate	Is a	Rosiglitazone (substance)	false	Inferred relationship	Some
Rosiglitazone maleate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peroxisome proliferator-activated gamma receptor agonist (disposition)	true	Inferred relationship	Some
Rosiglitazone maleate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Rosiglitazone (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Rosiglitazone maleate 2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Rosiglitazone maleate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	2
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rosiglitazone maleate	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
177440011	Rosiglitazone maleate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
674905017	Rosiglitazone maleate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
36131000188112	rosiglitazone maléate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
838871000172115	maléate de rosiglitazone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module